Effects of basal insulin therapy on postprandial glucose level

Effects of basal insulin therapy on postprandial glucose level - Effects of basal insulin therapy on postprandial glucose level

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000017637

Enrollment

Registered

2015-06-01

Start date

2015-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes mellitus

Interventions

Glargine Degludec

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: T2DM inpatients whose FPG level is above 150mg/dL.

Exclusion criteria

Exclusion criteria: untreated PPDR or PDR, nephropathy stage 4 or 5, acute glucose metabolic disturbance, cancer, acute illness, post-operation

Design outcomes

Primary

Measure	Time frame
amount of increase in plasma glucose level	—

Secondary

Measure	Time frame
CPR, proinsulin, adiponectin(HMW), high-sensitive TNF-alpha, IL-6, high-sensitive CRP, NEFA, BCAA	—

Countries

Japan

Contacts

Public ContactKazuma Ogiso

shima Medical Center Diabetes/Endocirne medicine

nomushi@kagomc2.hosp.go.jp099-223-1151

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026